1-7 of 7
Robert A. Vescio
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosis

Clinical Trials & Observations
Donna E. Reece, Ute Hegenbart, Vaishali Sanchorawala, Giampaolo Merlini, Giovanni Palladini, Joan Bladé, Jean-Paul Fermand, Hani Hassoun, Leonard Heffner, Vishal Kukreti, Robert A. Vescio, Lixia Pei, Christopher Enny, Dixie-Lee Esseltine, Helgi van de Velde, Andrew Cakana, Raymond L. Comenzo
Journal: Blood
Blood (2014) 124 (16): 2498–2506.
https://doi.org/10.1182/blood-2014-04-568329
Published: 2014
Includes: Supplemental data
Journal Articles

Efficacy and safety of once-weekly and twice-weekly bortezomib in patients with relapsed systemic AL amyloidosis: results of a phase 1/2 study

Clinical Trials & Observations
Donna E. Reece, Ute Hegenbart, Vaishali Sanchorawala, Giampaolo Merlini, Giovanni Palladini, Joan Bladé, Jean-Paul Fermand, Hani Hassoun, Leonard Heffner, Robert A. Vescio, Kevin Liu, Christopher Enny, Dixie-Lee Esseltine, Helgi van de Velde, Andrew Cakana, Raymond L. Comenzo
Journal: Blood
Blood (2011) 118 (4): 865–873.
https://doi.org/10.1182/blood-2011-02-334227
Published: 2011
Includes: Supplemental data
Journal Articles

Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study

Clinical Trials & Observations
Donna E. Reece, Vaishali Sanchorawala, Ute Hegenbart, Giampaolo Merlini, Giovanni Palladini, Jean-Paul Fermand, Robert A. Vescio, Xiangyang Liu, Yusri A. Elsayed, Andrew Cakana, Raymond L. Comenzo, for the VELCADE CAN2007 Study Group
Journal: Blood
Blood (2009) 114 (8): 1489–1497.
https://doi.org/10.1182/blood-2009-02-203398
Published: 2009
Includes: Supplemental data
Journal Articles

A Phase I/II Study of Xcellerated T Cells ™ after Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma.

David Siegel, MD, Ravi Vij, MD, Robert A. Vescio, MD, Ivan M. Borrello, MD, Thomas G. Martin, MD, James R. Berenson, MD, Christophe Ferrand, PhD, Fatimit Janmohamed, Ronald J. Berenson, MD, Mark W. Frohlich, MD
Journal: Blood
Blood (2004) 104 (11): 925.
https://doi.org/10.1182/blood.V104.11.925.925
Published: 2004
Journal Articles

Lack of serologic association of human herpesvirus-8 (KSHV) in patients with monoclonal gammopathy of undetermined significance with and without progression to multiple myeloma

Brief Report
Dharam V. Ablashi, Louise Chatlynne, David Thomas, Dimitra Bourboulia, Matthew B. Rettig, Robert A. Vescio, Dimitri Viza, Parkash Gill, Robert A. Kyle, James R. Berenson, James E. Whitman, Jr
Journal: Blood
Blood (2000) 96 (6): 2304–2306.
https://doi.org/10.1182/blood.V96.6.2304
Published: 2000
Journal Articles

HHV-8 Is Present in Multiple Myeloma Patients

James R. Berenson, Robert A. Vescio
Journal: Blood
Blood (1999) 93 (10): 3157–3159.
https://doi.org/10.1182/blood.V93.10.3157.410a40a_3157_3159
Published: 1999
Journal Articles

Localization of Kaposi's Sarcoma–Associated Herpesvirus in Bone Marrow Biopsy Samples From Patients With Multiple Myeloma

Jonathan W. Said, Matthew R. Rettig, Karen Heppner, Robert A. Vescio, Gary Schiller, Hong J. Ma, Daniel Belson, Alison Savage, I. Peter Shintaku, H. Phillip Koeffler, Hiroya Asou, Geraldine Pinkus, Jack Pinkus, Matthew Schrage, Eric Green, James R. Berenson
Journal: Blood
Blood (1997) 90 (11): 4278–4282.
https://doi.org/10.1182/blood.V90.11.4278
Published: 1997